4559:TYO
Zeria Pharmaceutical Co Ltd
1 903,00 JP¥
arrow_upward
+0,26%(+5,00) 1D
5 tet, 3:30:00 m.d., GMT+9 · JPY
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për 4559...
Hap
1 901 JP¥
I lartë
1 908 JP¥
I ulët
1 895 JP¥
Kapitalizimi i tregut
95,38 mld
Vëllimi mesatar
167,72 mijë
Vëllimi
125,40 mijë
Dividendi
2,57%
Dividendi tremujor
12 JP¥
Data e ndërprerjes së dividendit
29 sht 2026
Raporti çmim/fitim
10,19
Maksimumi 52-javor
2 434 JP¥
Minimumi 52-javor
1 878 JP¥
Fitimet për aksion
187 JP¥
Aksionet në qarkullim
50,11 mln
Numri i punonjësve
2 mijë
Hap
1 901 JP¥
I lartë
1 908 JP¥
I ulët
1 895 JP¥
Kapitalizimi i tregut
95,38 mld
Vëllimi mesatar
167,72 mijë
Vëllimi
125,40 mijë
Dividendi
2,57%
Dividendi tremujor
12 JP¥
Data e ndërprerjes së dividendit
29 sht 2026
Raporti çmim/fitim
10,19
Maksimumi 52-javor
2 434 JP¥
Minimumi 52-javor
1 878 JP¥
Fitimet për aksion
187 JP¥
Aksionet në qarkullim
50,11 mln
Numri i punonjësve
2 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
GlobeNewswire
·
36 minuta më parë
WISeQey Begins Trading on Nasdaq and SIX as WQEY
Simply Wall Street
·
1 orë më parë
Did New Science Board Just Shift BioCryst's (BCRX) Investment Narrative?
Los Angeles Times
·
8 minuta më parë
Stocks rise to the edge of an all-time high
Reuters
·
16 minuta më parë
COMMENTARY: TRADING DAY Nasdaq highs, Brazil surprise
Profili
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
Rreth Zeria Pharmaceutical Co Ltd
Drejtori ekzekutivSachiaki Ibe
Punonjësit1,75 mijë
Themeluar më22 dhj 1955
Selia-
Sektori-
Uebsajtizeria.co.jp